Our partners
Our strong and established network means we have a multitude of contacts and connections to ensure we know where to go and who to engage with, streamlining the pathway to commercialisation success that amplifies our impact. Our partnerships with venture capital firms and commercialisations funds offer funding, facilities, expertise and global markets to drive innovation through research.
Our current key commercialisation partners are:
Biocurate
BioCurate is a bold, collaborative venture, dedicated to translating Australian medical research and delivering health and economic benefits to the world. Their mission is to grow the Victorian and Australian biotech sector by translating medical research outputs into high quality pre-clinical candidates for the bio-pharmaceutical industry, venture capital companies and philanthropic funding agencies.
Brandon BioCatalyst
Brandon BioCatalyst is the largest life science investment fund in Australia and New Zealand. They are a collaboration between major Australian superannuation funds, CSL, the Australian and New Zealand governments, Australian state governments and more than 50 leading medical research institutes and research hospitals.
Breakthrough Victoria
Breakthrough Victoria supports breakthrough ideas and technologies to help solve globally significant problems, create industries of the future, improve health and wellbeing, and deliver prosperity and sustainable returns for Victoria over the next decade and beyond.
IP Group
IP Group was set up with a mission to evolve great ideas into world-changing businesses; to bridge the gap between cutting-edge scientific innovation and commercialisation; giving some of the best technological inventions the tools to succeed.
Uniseed
Uniseed is Australia’s longest running venture fund, operating at the Universities of Monash, Melbourne, Queensland, Sydney & New South Wales, and the CSIRO, with investment capital provided by these research organisations and a leading Australian Superannuation Fund, UniSuper. They invest across all sectors, including technology, physical sciences and life sciences.